देश: संयुक्त राज्य
भाषा: अंग्रेज़ी
स्रोत: NLM (National Library of Medicine)
FLUCONAZOLE (UNII: 8VZV102JFY) (FLUCONAZOLE - UNII:8VZV102JFY)
Major Pharmaceuticals
FLUCONAZOLE
FLUCONAZOLE 100 mg
ORAL
PRESCRIPTION DRUG
Fluconazole tablets are indicated for the treatment of: 1. Vaginal candidiasis (vaginal yeast infections due to Candida ) 2. Oropharyngeal and esophageal candidiasis. In open noncomparative studies of relatively small numbers of patients, fluconazole tablets were also effective for the treatment of Candida urinary tract infections, peritonitis, and systemic Candida infections including candidemia, disseminated candidiasis, and pneumonia. 3. Cryptococcal meningitis. Before prescribing fluconazole tablets for AIDS patients with cryptococcal meningitis, please see CLINICAL STUDIES section. Studies comparing fluconazole tablets to amphotericin B in non-HIV infected patients have not been conducted. Prophylaxis: Fluconazole tablets are also indicated to decrease the incidence of candidiasis in patients undergoing bone marrow transplantation who receive cytotoxic chemotherapy and/or radiation therapy. Specimens for fungal culture and other relevant laboratory studies (serology, histopathology) should be obtai
Fluconazole tablets USP, 100 mg are peach colored, oval, flat, bevelled edged, uncoated tablets debossed ‘R’ on one side and “144’ on other side and are supplied: Carton of 50 tablets (10 tablets per blister pack x 5), NDC 0904-6500-06 Carton of 100 tablets (10 tablets per blister pack x 10), NDC 0904-6500-61 Fluconazole tablets USP, 200 mg are peach colored, oval, flat, bevelled edged, uncoated tablets debossed ‘R’ on one side and “146’ on other side and are supplied: Carton of 50 tablets (10 tablets per blister pack x 10), NDC 0904-6501-06 Carton of 100 tablets (10 tablets per blister pack x 10), NDC 0904-6501-61 Storage: Store at 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature]. Maalox®is a registered trademark of Novartis Consumer Health, Inc. XELJANZ®is a registered trademark of Pfizer Inc.
Abbreviated New Drug Application
FLUCONAZOLE- FLUCONAZOLE TABLET MAJOR PHARMACEUTICALS ---------- FLUCONAZOLE TABLETS USP DESCRIPTION Fluconazole, the first of a new subclass of synthetic triazole antifungal agents, is available as tablets for oral administration. Fluconazole is designated chemically as 2,4-difluoro-α,α -bis(1H-1,2,4-triazol-1-ylmethyl) benzyl alcohol with a molecular formula of C H F N O and molecular weight of 306.3. The structural formula is: Fluconazole USP is a white or almost white crystalline powder, which is freely soluble in methanol, soluble in alcohol and in acetone, sparingly soluble in isopropyl alcohol and in chloroform. Slightly soluble in water, very slightly soluble in toluene. Fluconazole tablets USP contain 50 mg, 100 mg, 150 mg, or 200 mg of fluconazole USP and the following inactive ingredients: dibasic calcium phosphate anhydrous, ferric oxide (iron oxide, red), magnesium stearate, microcrystalline cellulose, povidone, sodium starch glycolate, and starch. Fluconazole tablets meets USP _Dissolution_ Test 2. CLINICAL PHARMACOLOGY PHARMACOKINETICS AND METABOLISM The pharmacokinetic properties of fluconazole are similar following administration by the intravenous or oral routes. In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration. Bioequivalence was established between the 100 mg tablet and both suspension strengths when administered as a single 200 mg dose. Peak plasma concentrations (C ) in fasted normal volunteers occur between 1 and 2 hours with a terminal plasma elimination half-life of approximately 30 hours (range: 20 to 50 hours) after oral administration. In fasted normal volunteers, administration of a single oral 400 mg dose of fluconazole leads to a mean C of 6.72 mcg/mL (range: 4.12 to 8.08 mcg/mL) and after single oral doses of 50 to 400 mg, fluconazole plasma concentrations and area under the plasma concentration-time curve (AUC) are dose proportional. 1 13 12 2 6 max max The C and AUC data from a food-effect study in पूरा दस्तावेज़ पढ़ें